AGIO
Agios Pharmaceuticals, Inc.Company with tickers: AGIO
CIK
1439222
CUSIP
00847X104
Shares Outstanding
59,471,609
13F Activity (30d)
204 filings
201 filers
Price
$28.60
Market Cap
$1.67B
P/E Ratio
-4.02
EPS (Diluted)
$-7.12
52W High
$46.00
52W Low
$22.24
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $20,746,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $81,148,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Operating Income | $-110,025,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Net Income | $-99,111,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Basic) | $-1.69 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Diluted) | $-1.69 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |